
--- Page 1 ---
UUID:48DB8720-833D-467C-8BF2-95EF539B4D5E TCGA-CF-A1HS-01A-PR Redacted rorm kevised Clinical Case Report icd-0-3 Carcnoma, Squsmorg cilL,NcS Idka- demoid.Nos) 8070/3 Criteria Siter bInddw,NoS c47.9 14 Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research purposes.I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator. Signature Date Clinical Information ODATKSGENERALINFORMATIONCSAN Date of Birth (mm/dd/vyyy) Height  Marital Status Race Temperature Gender Weight Blood Pressure Heart Rate  Male Female 5 2 F0j 141 T8 YOGSPEMAHISTORYOEPRESENTILLNESS Symptoms: Hematr ; Weighf Loss Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic   80-90 Symptomatic but Fully Ambulatory.  60-70 Symptomatic, in bed less than 50% of day. 40-50 Symptomatic, in bed more than 50% of day, but not bed ridden.   20-30 Bed Ridden RWNCURRENTMEDICATIONS..C Drug Dose Route Frequency Date (mm/dd/yyyy) To To To To / 1 1 To /

--- Page 2 ---
PAST MEDICAL HISTORY  Diagnosis/Disease/Disorder/Injury Diagnosis Date Treatment Status CPKAOBGYNHISTORYP  Menopausa! Status Date of First Menses # of Pregnancies  Pre-menopausal -okc4  Peri-Menopausa! Date of Last Menses # of Live Births Post-menopausa! Birth Control:  Condom  Oral Contraceptive A IUD  Hormone Replacement  Other: Therapy: WSOCIALHISTORYAX Occupation: Environmental Hazards: Smoking History Current Status TYPE  Packs/day  Duration When Quit YES NO (yrs) (yr) Alcohol Consumption Current Status TYPE Drinks/day. Duration When Quit  yes  NO (yrs) (yr) Drug Use Current Status TYPE Freguency  Duration When Quit  yes ZNO (yrs) (yr) MRWCAFAMILYMEDICALHISTORYEE Relative  Diagnosis Age of Diagnosis Test Result Date Test Result Date HIV p Negative  Positive: CEA   Negative  Positive: Hep B  Negative  Positive: CA 15-3   Negative  Positive: Hep C Negative  Positive: CA 19-9   Negative  Positive: AFP  Negative  Positive: PSA  Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
ADIAGNOSTICSTUDIESROC Study Results Date Ultrasound  A tonwy w the U.bladden: X-Ray  CT Endoscopy MRI Biopsy PASNACLINICALDIAGNOSISOAR. Preoperative Clinical Diagnosise Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis. Clinical Staging Date of Diagnosis T3 No Mo Stage: 1 Treatment Information SEAHESURGICALTREATMENTENOAAE Procedure Date of Procedure. U. Bledder Reseeti'm Primary Tumor Organ Detailed Location Size Bletdefer lumtR QprinerQ 5x 4x2 cm Extension of Tumor. Lymph Nodes Description Location of Lymph Nodes. # of Lymph Nodes. Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size Surgical Staging T3 No mo Stage: 7U Dose Route Frequency Drug/Treatment Date (mm/dd/yyy) To / To / / To To / To 3

--- Page 4 ---
Pathology Form Specimen Information Collected by Date Preserved by: Date: SPECIMENTYPE #of samples provided  Blood/Serum/Plasma Slide Frozen Paraffin Block Diseased Normal Diseased Normal Diseased Normal Diseased Normal 2 4 Time to LN2 Time to Formalin Time to LN2 min 12 min min EAA PATHOLOGICALDESCRIPTIONE A Primary Tumor Organ Size Extension of Tumor Distance to NAT 5 hladeden 3 x4 x2 cm cm Lymph Nodes Location. # Examined # Metastasized Distant Metastasis  Organ Detailed Location Size Pathological Staging Mo pT 3 No Stage: ! Notes: 4

--- Page 5 ---
Microscopic Description aHistologicalPatternawan Cell Distribution + Structural Pattern + Diffuse  Streaming Mosaic  Storiform  Necrosis Fibrosis Lymphocytic Infiltration  Palisading Vascular Invasion  Cystic Degeneration Clusterized Bleeding  Alveolar Formation  Myxoid Change  Indian File  Psammoma/Calcification a.CelluaDifferentiationwa Squamous +- Adenomatous +-  Sarcomatous +-  Lymphomatous + Squamoid Cell X Glandular cell  Round Cell  Large Cell Spindle Cell Cell Stratification Fibroblast Small Cell  Keratin Secretion  Osteoblast  RS Cell/RS Like  Desmosome Intracyt. Vacuole Lipoblast Inflam. Cell  Pearl Gland formation Myoblast  Plasma Cell Cellular Differentiation: Well I9 Moderate  Poor Bhxa NuclearAppearancerw Nuclear Atypia: 0 I II III Aniso Nucleosis Hyperchromatism Nucleolar Prominent  Multinucleated Giant Cell Mitotic Activity Nuclear Grade: Marker Result Value Date ER  Negative Positive PR  Negative  Positive Her-2/neu  Negative  Positive B-Cell Marker  Negative_ Positive T-Cell Marker  Negative  Positive Other:  Negative   Positive Other:  Negative  Positive Final Pathology Report 8070|3 E0j o(er mv` crrcirum) cf The folecleleR Histological Diagnosis: Grade: Comments:  Principal Investigator Pathologist Date 5

--- Page 6 ---
COnsOLIdaTeD DIagnOstIc PathoLOgy fOrm* Microscopic Appearance: Histological pattern: CELL DISTRIBUTION Diffuse STRUCTURAL PATTERN Mosaic XStreaming Necrosis  Storiform Lymphocytic Infiltration Fibrosis Vascular Invasion x Palisading Clusterized X Cystic Degeneration Alveolar Formation X Bleeding Indian File Myxoid Change 2. Cellular features. Psammoma/Calcification Squamous Adenomatous +  Sarcoratous  Squamoid Cell x Lymphomatous Glandular cell Round Cell Spindle Cell Large Cell Cell Stratification Fibroblast Keratin Small Cell Secretion Osteoblast  RS Cell/RS Like Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell Pear! X Gland formation Myoblast  Plasma Cell Otherwise Specified: D1 75 D275%  d775%. 7s% 2.Cellular Differentiation: R0~TY Well Moderately Poo Nuclear Atypia: Nucitar Appearance Aniso Nucleosis Hyperchromatism X Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuckear Grade X 8074/3 Histological Diagnosis: SQn ohsus Ce/ Care>jro. Comments: Date Director, Research Pathology PATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR ANDE